Kim R Tsuchimoto has sold MNPR and made no open-market buys since Aug 2026

Director at Monopar Therapeutics Inc.

SEC CIK 0001333516 · Filings on SEC.gov ↗

Filings come from SEC EDGAR. Not investment advice.